Co-Authors
This is a "connection" page, showing publications co-authored by Evangelos Giamarellos-Bourboulis and Nikolaos Gatselis.
Connection Strength
0.709
-
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
Score: 0.241
-
Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19. Eur J Intern Med. 2021 06; 88:52-62.
Score: 0.234
-
An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
Score: 0.233